FDA Approvals in Oncology: April-June 2026
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
Tag: Kidney cancer
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Researchers are exploring new options for kidney cancer treatments.
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...
For Bruce Hill, who was diagnosed with stage 4 clear cell renal cell carcinoma (RCC) in 2017, scientific progress...
A highly complex filtering system, the kidneys process roughly half a cup of blood every minute, isolating waste and...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...